{"id":"W4407758786","doi":"10.51731/cjht.2025.1078","title":"Pembrolizumab (Keytruda)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Cancer Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Pembrolizumab; Medicine; Internal medicine; Cancer","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003553238,0.0002069291,0.000329004,0.0004639998,0.0003401452,0.0006928774,0.0004808893,0.0006276233,0.01863213],"category_scores_gemma":[0.0006695077,0.0001049516,0.0003430406,0.0003346134,0.0001690606,0.0004328743,0.000381701,0.001598806,0.004843794],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001421087,"about_ca_system_score_gemma":0.001704164,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01428665,"about_ca_topic_score_gemma":0.03035376,"domain_scores_codex":[0.9997799,0.00002503536,0.00001500571,0.00003256767,0.00009360567,0.00005389961],"domain_scores_gemma":[0.9997793,0.00002662204,0.00003776977,0.00001299528,0.00005944763,0.00008383434],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.001567943,0.0003092063,0.001050919,0.001064062,0.00007697743,0.0005371317,0.0000405953,0.0002448191,0.01130332,0.003226327,0.1757875,0.8047911],"study_design_scores_gemma":[0.001938092,0.0008156536,0.007152695,0.0005556862,0.00009751085,0.001956261,0.00002724517,0.0003069841,0.003794604,0.0007403375,0.9825953,0.00001946306],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"other","genre_gemma":"other","genre_scores_codex":[0.0781858,0.3767001,0.007167059,0.04146,0.004895195,0.001617228,0.01097457,0.002549434,0.4764506],"genre_scores_gemma":[0.545508,0.1579796,0.01223264,0.02394339,0.001821428,0.0008910447,0.01264555,0.0001856782,0.2447926],"genre_candidate":"other","genre_consensus":"other","teacher_disagreement_score":0.01863213,"threshold_uncertainty_score":0.0623306,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01842399516344367,"score_gpt":0.3173981953308042,"score_spread":0.2989742001673605,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}